Education
About Us
Working with TipRanks
Follow Us
Scandinavian ChemoTech AB Class B (SE:CMOTEC.B)
:CMOTEC.B
RESEARCH TOOLSreports
Total Valuation
Scandinavian ChemoTech AB Class B has a market cap or net worth of kr34.20M. The enterprise value is ―.
Market Capkr34.20M
Enterprise Value―
Share Statistics
Scandinavian ChemoTech AB Class B has 21,692,312 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding21,692,312
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Scandinavian ChemoTech AB Class B’s return on equity (ROE) is -2.29 and return on invested capital (ROIC) is -213.98%.
Return on Equity (ROE)-2.29
Return on Assets (ROA)-1.03
Return on Invested Capital (ROIC)-213.98%
Return on Capital Employed (ROCE)-2.14
Revenue Per Employee1.09M
Profits Per Employee0.00
Employee Count6
Asset Turnover0.49
Inventory Turnover0.54
Valuation Ratios
The current PE Ratio of Scandinavian ChemoTech AB Class B is -2.70. Scandinavian ChemoTech AB Class B’s PEG ratio is 0.05.
PE Ratio-2.70
PS Ratio―
PB Ratio6.18
Price to Fair Value6.18
Price to FCF-2.81
Price to Operating Cash Flow-2.81
PEG Ratio0.05
Income Statement
In the last 12 months, Scandinavian ChemoTech AB Class B had revenue of 6.57M and earned -13.72M in profits. Earnings per share was -0.66.
Revenue6.57M
Gross Profit4.78M
Operating Income-12.80M
Pretax Income-13.72M
Net Income-13.72M
EBITDA-10.73M
Earnings Per Share (EPS)-0.66
Cash Flow
In the last 12 months, operating cash flow was -13.14M and capital expenditures 0.00, giving a free cash flow of -13.14M billion.
Operating Cash Flow-13.14M
Free Cash Flow-13.14M
Free Cash Flow per Share-0.61
Dividends & Yields
Scandinavian ChemoTech AB Class B pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.31
52-Week Price Change-31.92%
50-Day Moving Average1.19
200-Day Moving Average1.66
Relative Strength Index (RSI)59.74
Average Volume (3m)45.89K
Important Dates
Scandinavian ChemoTech AB Class B upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateMar 4, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Scandinavian ChemoTech AB Class B as a current ratio of 1.05, with Debt / Equity ratio of 0.00%
Current Ratio1.05
Quick Ratio0.60
Debt to Market Cap0.00
Net Debt to EBITDA0.09
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Scandinavian ChemoTech AB Class B has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Scandinavian ChemoTech AB Class B EV to EBITDA ratio is -3.36, with an EV/FCF ratio of -2.74.
EV to Sales5.49
EV to EBITDA-3.36
EV to Free Cash Flow-2.74
EV to Operating Cash Flow-2.74
Balance Sheet
Scandinavian ChemoTech AB Class B has kr949.00K in cash and marketable securities with kr0.00 in debt, giving a net cash position of -kr949.00K billion.
Cash & Marketable Securitieskr949.00K
Total Debtkr0.00
Net Cash-kr949.00K
Net Cash Per Share-kr0.04
Tangible Book Value Per Sharekr0.29
Margins
Gross margin is -123.99%, with operating margin of -194.88%, and net profit margin of -208.91%.
Gross Margin-123.99%
Operating Margin-194.88%
Pretax Margin-208.91%
Net Profit Margin-208.91%
EBITDA Margin-163.46%
EBIT Margin-194.88%
Analyst Forecast
The average price target for Scandinavian ChemoTech AB Class B is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast132.67%
EPS Growth Forecast58.89%